Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles. Chittasupho C*, Lirdprapamongkol K, Kewsuwan P, Sarisuta N. Eur J Pharm Biopharm. 2014 Oct;88(2):529-38.

01 Oct 2014
0

Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles.

Chittasupho C*, Lirdprapamongkol K, Kewsuwan P, Sarisuta N.

Eur J Pharm Biopharm. 2014 Oct;88(2):529-38.

Tags

Share this

Related Posts

Bridging the gap between clinicians and systems biologists: From network biology to translational biomedical research. Jinawath N, Bunbanjerdsuk S, Chayanupatkul M, Ngamphaiboon N, Asavapanumas N, Svasti J, Charoensawan V*. J Transl Med 2016;14(1):324.
Sureram, S.; Wiyakrutta, S.; Ngamrojanavanich, N.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Depsidones, Aromatase Inhibitors and Radical Scavenging Agents from the Marine-Derived Fungus Aspergillus unguis CRI282-03. Planta Med. 2012 ,78(6), 582-588

Recent Posts